SMTL ID : 1lya.2 (1 other biounit)

CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-2-2-mer

Ligands

2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.1: 6 residues within 4Å: Chain A: N.70, T.72, Q.89 Chain B: V.9, N.40, N.41 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:N.41, B:N.40 Hydrophobic interactions: B:N.40, A:T.72 NAG-NAG-BMA-MAN.3: 9 residues within 4Å: Chain C: K.69, N.70, T.72, L.87 Chain D: V.9, N.40, N.41, V.42, L.43 1 PLIP interactions: 1 interactions with chain D Hydrogen bonds: D:N.41, D:N.41, D:L.43

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 3 residues within 4Å: Chain B: Y.92, L.93, N.94 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.94 NAG.4: 3 residues within 4Å: Chain D: Y.92, L.93, N.94 2 PLIP interactions: 2 interactions with chain D Hydrogen bonds: D:N.94, D:N.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baldwin, E.T. et al., Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc.Natl.Acad.Sci.USA (1993)

Release Date

1994-01-31

Peptides

CATHEPSIN D: AC
CATHEPSIN D: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

CATHEPSIN D

CATHEPSIN D

Related Entries With Identical Sequence